Immune-Onc Therapeutics, Inc.

Release Summary

Immune-Onc Therapeutics, Inc. Announces Licensing and Collaboration with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center to Develop Novel Cancer Immunotherapy

Immune-Onc Therapeutics, Inc.